Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ATHA Athira Pharma Inc

2,1213

0,1513 (7,68%)

08 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Athira Pharma Charts.

Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Athira Pharma Charts.

News Athira Pharma Inc

Athira Pharma to Participate in Upcoming May Conferences
Donnerstag 2 Mai 2024 (6 Tage vor) • GlobeNewswire Inc.

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Montag 15 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
Donnerstag 11 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
Mittwoch 3 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
Freitag 8 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
Donnerstag 22 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Athira Pharma Inc News-Artikel

Gold vs US Dollar

Deutsche Lufthansa

Financial Select Sector

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen